\-\ Texto\\:\\ \ \(0\)\
\-\ well\\ elderly\\ male\\ with\\ palpable\\ gastric\\ mass\\.\\ \ \(0\)\
\-\ cbc\\,\\ chemistry\\,\\ and\\ coagulation\\ panels\\ all\\ within\\ normal\\ limits\\.\\ heliobacter\\ pylori\\ positive\\.\ \(0\)\
\-\ heliobacter\\ pylori\\ eradication\\,\\ chemotherapy\ \(0\)\
\-\ \\â\\€\\¢a\\ long\\ segment\\ of\\ the\\ gastric\\ wall\\ lesser\\ curvature\\ is\\ asymmetrically\\ thickened\\ to\\ 23mm\\.\\ the\\ fat\\ plane\\ between\\ the\\ liver\\ and\\ the\\ stomach\\ appears\\ to\\ be\\ preserved\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢additional\\ findings\\ not\\ shown\\ in\\ selected\\ image\\:\\ a\\ 9\\ mm\\ lymph\\ node\\ is\\ present\\ between\\ the\\ stomach\\ and\\ the\\ liver\\.\\ an\\ 11mm\\ pancreatic\\ node\\ is\\ seen\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ the\\ liver\\,\\ spleen\\,\\ gallbladder\\,\\ pancreas\\,\\ and\\ adrenal\\ glands\\ are\\ unremarkable\\.\\ a\\ 3\\.2\\ cm\\ simple\\ cyst\\ is\\ seen\\ in\\ the\\ superior\\ pole\\ of\\ the\\ right\\ kidney\\.\\ the\\ left\\ kidney\\ is\\ unremarkable\\.\ \(0\)\
\-\ gastric\\ malt\\ lymphoma\\,\\ poorly\\ differentiated\ \(0\)\
\-\ \\â\\€\\¢\\ adenocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ gastric\\ lymphoma\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ gastritis\ \(0\)\
\-\ 75\\ y\\/o\\ man\\ with\\ a\\ history\\ of\\ chronic\\ active\\ gastritis\\ and\\ refractory\\ gastric\\ ulcer\\.\\ \\ a\\ 6\\ cm\\ by\\ 6\\ cm\\ gastric\\ mass\\ found\\ on\\ esophagogastroduodenoscopy\\ \\(egd\\)\\.\ \(0\)\
\-\ gastric\\ malt\\ lymphoma\\ is\\ associated\\ with\\ h\\ pylori\\ infection\\.\\ while\\ eradication\\ of\\ h\\ pylori\\ is\\ often\\ \\(60\\-75\\%\\)\\ sufficient\\ to\\ effect\\ remission\\,\\ higher\\ grade\\ lesions\\,\\ as\\ evidenced\\ by\\ the\\ lesion\\'s\\ histopathology\\ require\\ additional\\ chemotherapy\\.\\ this\\ patient\\ achieved\\ full\\ remission\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gastric\\:\\ 0\\.12260616078631506\ \(0\)\
\-\ pylori\\:\\ 0\\.1146893406698158\ \(0\)\
\-\ heliobacter\\:\\ 0\\.08087631581620641\ \(0\)\
\-\ eradication\\:\\ 0\\.0707973039935632\ \(0\)\
\-\ malt\\:\\ 0\\.06815801892519824\ \(0\)\
\-\ gastritis\\:\\ 0\\.0573446703349079\ \(0\)\
\-\ remission\\:\\ 0\\.055439722034190064\ \(0\)\
\-\ h\\:\\ 0\\.04126633312321274\ \(0\)\
\-\ liver\\:\\ 0\\.04054433271788152\ \(0\)\
\-\ \\â\\€\\¢a\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ \\â\\€\\¢additional\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ 23mm\\:\\ 0\\.03725858368535116\ \(0\)\
\-\ esophagogastroduodenoscopy\\:\\ 0\\.03725858368535116\ \(0\)\
\-\ 60\\-75\\:\\ 0\\.03725858368535116\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.035940696137520364\ \(0\)\
\-\ node\\:\\ 0\\.035873794913101546\ \(0\)\
\-\ stomach\\:\\ 0\\.034665741482136414\ \(0\)\
\-\ 11mm\\:\\ 0\\.03407900946259912\ \(0\)\
\-\ lymphoma\\:\\ 0\\.033608238087928705\ \(0\)\
\-\ panels\\:\\ 0\\.032219077774029554\ \(0\)\
\-\ cm\\:\\ 0\\.03154068052041724\ \(0\)\
\-\ asymmetrically\\:\\ 0\\.03151196456381278\ \(0\)\
\-\ chemistry\\:\\ 0\\.030359146085459993\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.028100420047163902\ \(0\)\
\-\ coagulation\\:\\ 0\\.027719861017095032\ \(0\)\
\-\ curvature\\:\\ 0\\.027719861017095032\ \(0\)\
\-\ kidney\\:\\ 0\\.027618196835321192\ \(0\)\
\-\ 3\\.2\\:\\ 0\\.027179571862707953\ \(0\)\
\-\ egd\\:\\ 0\\.0266962667450115\ \(0\)\
\-\ evidenced\\:\\ 0\\.0266962667450115\ \(0\)\
\-\ unremarkable\\:\\ 0\\.02595473778607395\ \(0\)\
\-\ between\\:\\ 0\\.02484858290113985\ \(0\)\
\-\ achieved\\:\\ 0\\.02483633505644194\ \(0\)\
\-\ sufficient\\:\\ 0\\.024399132396789074\ \(0\)\
\-\ refractory\\:\\ 0\\.024262192198854757\ \(0\)\
\-\ lesser\\:\\ 0\\.02412922184622516\ \(0\)\
\-\ selected\\:\\ 0\\.023751982863486756\ \(0\)\
\-\ 6\\:\\ 0\\.023413946434631877\ \(0\)\
\-\ glands\\:\\ 0\\.023292884429739126\ \(0\)\
\-\ preserved\\:\\ 0\\.023184946368224477\ \(0\)\
\-\ elderly\\:\\ 0\\.023079489862606592\ \(0\)\
\-\ plane\\:\\ 0\\.021892051174917194\ \(0\)\
\-\ histopathology\\:\\ 0\\.021892051174917194\ \(0\)\
\-\ ulcer\\:\\ 0\\.02158093834767517\ \(0\)\
\-\ spleen\\:\\ 0\\.021082617976102714\ \(0\)\
\-\ differentiated\\:\\ 0\\.020949647623473115\ \(0\)\
\-\ pancreas\\:\\ 0\\.020059023704019182\ \(0\)\
\-\ 75\\:\\ 0\\.020059023704019182\ \(0\)\
\-\ adrenal\\:\\ 0\\.019848082817588802\ \(0\)\
\-\ simple\\:\\ 0\\.019313524027423885\ \(0\)\
\-\ higher\\:\\ 0\\.019222686287533153\ \(0\)\
\-\ pancreatic\\:\\ 0\\.0191779331914535\ \(0\)\
\-\ poorly\\:\\ 0\\.019133612499197827\ \(0\)\
\-\ gallbladder\\:\\ 0\\.01883480836079892\ \(0\)\
\-\ pole\\:\\ 0\\.018253378518417525\ \(0\)\
\-\ is\\:\\ 0\\.018055208480243484\ \(0\)\
\-\ require\\:\\ 0\\.017936897456550773\ \(0\)\
\-\ thickened\\:\\ 0\\.017577577074578726\ \(0\)\
\-\ cbc\\:\\ 0\\.017515165826616438\ \(0\)\
\-\ segment\\:\\ 0\\.017100560040064744\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.016933735984235043\ \(0\)\
\-\ full\\:\\ 0\\.016933735984235043\ \(0\)\
\-\ 9\\:\\ 0\\.016203278418479405\ \(0\)\
\-\ limits\\:\\ 0\\.01615694311578902\ \(0\)\
\-\ lymph\\:\\ 0\\.01582358903185618\ \(0\)\
\-\ shown\\:\\ 0\\.015717645386009164\ \(0\)\
\-\ additional\\:\\ 0\\.015717645386009164\ \(0\)\
\-\ seen\\:\\ 0\\.01549199646851092\ \(0\)\
\-\ active\\:\\ 0\\.014965866234150828\ \(0\)\
\-\ grade\\:\\ 0\\.01493044400436225\ \(0\)\
\-\ appears\\:\\ 0\\.014590499177969032\ \(0\)\
\-\ mm\\:\\ 0\\.014413739251353237\ \(0\)\
\-\ palpable\\:\\ 0\\.01389275707614583\ \(0\)\
\-\ effect\\:\\ 0\\.013878707582886445\ \(0\)\
\-\ long\\:\\ 0\\.013514777572627173\ \(0\)\
\-\ by\\:\\ 0\\.013053861497659401\ \(0\)\
\-\ positive\\:\\ 0\\.01271965867102806\ \(0\)\
\-\ superior\\:\\ 0\\.012517172922266933\ \(0\)\
\-\ often\\:\\ 0\\.01250675939687914\ \(0\)\
\-\ \\,\\:\\ 0\\.012417892913637036\ \(0\)\
\-\ found\\:\\ 0\\.012353328506661066\ \(0\)\
\-\ while\\:\\ 0\\.012333253393817953\ \(0\)\
\-\ image\\:\\ 0\\.012243987001365142\ \(0\)\
\-\ fat\\:\\ 0\\.011921616160007493\ \(0\)\
\-\ infection\\:\\ 0\\.01139457144070095\ \(0\)\
\-\ wall\\:\\ 0\\.011353940918526359\ \(0\)\
\-\ all\\:\\ 0\\.011086804997391243\ \(0\)\
\-\ chronic\\:\\ 0\\.011041236848197248\ \(0\)\
\-\ mass\\:\\ 0\\.01090331199034463\ \(0\)\
\-\ y\\/o\\:\\ 0\\.010856096467062572\ \(0\)\
\-\ cyst\\:\\ 0\\.010533812550578453\ \(0\)\
\-\ lesions\\:\\ 0\\.010493396818091505\ \(0\)\
\-\ metastatic\\:\\ 0\\.009867474328514175\ \(0\)\
\-\ man\\:\\ 0\\.009270329555458713\ \(0\)\
\-\ associated\\:\\ 0\\.00924982826563166\ \(0\)\
\-\ \\%\\:\\ 0\\.009143674464889943\ \(0\)\
\-\ well\\:\\ 0\\.008867343820957115\ \(0\)\
\-\ present\\:\\ 0\\.008853251164824225\ \(0\)\
\-\ \\'s\\:\\ 0\\.008642415680582776\ \(0\)\
\-\ findings\\:\\ 0\\.008343288696284219\ \(0\)\
\-\ lesion\\:\\ 0\\.007984198284405756\ \(0\)\
\-\ within\\:\\ 0\\.007477667010945329\ \(0\)\
\-\ a\\:\\ 0\\.007277060583827546\ \(0\)\
\-\ male\\:\\ 0\\.00708809879764896\ \(0\)\
\-\ the\\:\\ 0\\.006975881338256348\ \(0\)\
\-\ \\(\\:\\ 0\\.0066271718004023905\ \(0\)\
\-\ \\)\\:\\ 0\\.006546217358837662\ \(0\)\
\-\ disease\\:\\ 0\\.0064070529413564415\ \(0\)\
\-\ normal\\:\\ 0\\.006145011259628904\ \(0\)\
\-\ be\\:\\ 0\\.0060447556116694\ \(0\)\
\-\ as\\:\\ 0\\.005929254614193247\ \(0\)\
\-\ to\\:\\ 0\\.005877084061142013\ \(0\)\
\-\ not\\:\\ 0\\.005664305833678603\ \(0\)\
\-\ an\\:\\ 0\\.005420481028829036\ \(0\)\
\-\ history\\:\\ 0\\.0054138281546196486\ \(0\)\
\-\ are\\:\\ 0\\.005343458130869733\ \(0\)\
\-\ \\:\\:\\ 0\\.005184746862342501\ \(0\)\
\-\ this\\:\\ 0\\.004408886299606115\ \(0\)\
\-\ left\\:\\ 0\\.004385803987490435\ \(0\)\
\-\ right\\:\\ 0\\.0041359252711487\ \(0\)\
\-\ and\\:\\ 0\\.004128646920463726\ \(0\)\
\-\ patient\\:\\ 0\\.003929320784020128\ \(0\)\
\-\ in\\:\\ 0\\.0038660296343142656\ \(0\)\
\-\ on\\:\\ 0\\.00332060097415334\ \(0\)\
\-\ \\.\\:\\ 0\\.0024426286305513495\ \(0\)\
\-\ of\\:\\ 0\\.0021376844183117146\ \(0\)\
\-\ with\\:\\ 0\\.0016101492122461891\ \(0\)\
